Status:
COMPLETED
The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting (CABG) Surgery
Lead Sponsor:
Tampere University Hospital
Conditions:
Heart Valve Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Patients undergoing aortic valve replacement (AVR) surgery with coronary artery bypass grafting (CABG) are at risk of left ventricular dysfunction. The aim of the study is to describe the haemodynamic...
Eligibility Criteria
Inclusion
- LVEF less than 50% of left ventricular hypertrophy indicated by wall thickness more than 12mm
Exclusion
- allergy to levosimendan
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01210976
Start Date
January 1 2009
End Date
September 1 2010
Last Update
September 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland